OGN (Organon) Inventories, Other: $1,351 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OGN Organon & Co OGN
71 GF Score
Price $13.60
GF Value $13.44
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Organon Inventories, Other?

Organon OGN +0.37% 71 Inventories, Other is $1,351 Mil as of Jun. 2026. GuruFocus rates OGN with a GF Score™ of 71/100 and a GF Value™ of $13.44 (Fairly Valued). The stock has 11 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Organon's other inventories for the quarter that ended in Jun. 2026 was $1,351 Mil.

Organon's quarterly other inventories declined from Dec. 2025 ($1,406 Mil) to Mar. 2026 ($1,373 Mil) and declined from Mar. 2026 ($1,373 Mil) to Jun. 2026 ($1,351 Mil).

Organon's annual other inventories increased from Dec. 2023 ($1,315 Mil) to Dec. 2024 ($1,321 Mil) and increased from Dec. 2024 ($1,321 Mil) to Dec. 2025 ($1,406 Mil).

Organon Inventories, Other Historical Data

* Premium members only.

The historical data trend for Organon's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organon Inventories, Other Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial 915.00 1,003.00 1,315.00 1,321.00 1,406.00

Organon Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,454.00 1,488.00 1,406.00 1,373.00 1,351.00
OGN
71GF Score
Organon & Co OGN
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organon Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of $1,351 Mil mean?
Organon (OGN) has a Inventories, Other of $1,351 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Organon and its competitors.
Is Organon's Inventories, Other too high?
Organon's current Inventories, Other is $1,351 Mil. Overall, Organon has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Organon's Inventories, Other compare to AMRN and SCLX?
Organon's Inventories, Other of $1,351 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Drug Manufacturers company?
A good Inventories, Other depends on the Drug Manufacturers industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Organon and its competitors. Organon's current Inventories, Other is $1,351 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organon stock overvalued right now?
Based on GuruFocus' analysis, Organon (OGN) is currently considered Fairly Valued. The stock's GF Value™ is $13.44, compared to a current price of $13.60 — trading 1.2% above its estimated fair value. The current Inventories, Other is $1,351 Mil. Organon's overall GF Score™ is 71/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Organon (OGN), the current Inventories, Other is $1,351 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organon (OGN) Overvalued in 2026?

Based on GuruFocus' analysis, Organon stock appears to be overvalued. The current stock price of $13.60 is trading 1.2% above its estimated GF Value™ of $13.44. GuruFocus considers Organon to be Fairly Valued.

Key valuation signals for OGN:

  • Inventories, Other: $1,351 Mil
  • GF Value™: $13.44 vs. price of $13.60 (1.2% above fair value)
  • GF Score™: 71/100 with 11 warning signs

No single metric tells the full story. See the OGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organon Business Description

Address 30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
71GF Score

Get the complete analysis for OGN

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.60
Price
$13.44
GF Value